Latest Breaking News On - Director leukemia research alliance program - Page 1 : comparemela.com

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAptose biosciencesRafael bejarExchange commissionInternational phaseUniversity of texas md anderson cancer centerAptosebiosciencesinc susan pietropaolocorporate communications investor relationsLeukemia research alliance programAptose biosciences incAmerican society of hematologyDepartment of leukemiaReporting complete response dataDemonstrate favorable safetyActive across broad populationsComplete response rate among all comersAchieve responses

Aptose Tuspetinib Clinical Data Featured in Oral

Aptose Tuspetinib Clinical Data Featured in Oral
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRafael bejarSusan pietropaoloAptose biosciencesCorporate communications investor relationsInternational phaseAptose biosciences incUniversity of texas md anderson cancer centerAmerican society of hematologyDepartment of leukemiaExchange commissionLeukemia research alliance programReporting complete response dataDemonstrate favorable safetyActive across broad populationsComplete response rate among all comers

Aptose Reports Results for the Third Quarter 2023

Aptose Reports Results for the Third Quarter 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAptose biosciencesSusan pietropaoloAptose biosciences inc statements of operations dataAptose biosciences inc balance sheet dataEuropean school of haematologyDepartment of leukemiaCorporate communications investor relationsLeukemia research alliance programUniversity of texas md anderson cancer centerAptose biosciences incAmerican society of hematologyExchange commissionTargets venetoclaxTherapy active

Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting

Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego convention centerSusan pietropaoloAptose biosciencesCorporate communications investor relationsAmerican society of hematologyLeukemia research alliance programUniversity of texas md anderson cancer centerAptose biosciences incDepartment of leukemiaInternational phaseAmerican societyAnnual meetingNaval daverDirector leukemia research alliance program

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSusan pietropaoloRafael bejarAptose biosciencesAptose biosciences incLeukemia research alliance programUniversity of texas md anderson cancer centerEuropean school of haematologyDepartment of leukemiaInternational conferenceExchange commissionLifesci advisorsPresents highlightsClinical findingsHeavily pre treatedFavorable safety